Candelaria Gomez-Manzano

14PUBLICATIONS
61CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersRadiation therapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 16, 2026
Diverse origin and nature of tumor-infiltrating lymphocytes: the infection hypothesis.

|Jan 29, 2026
Systemic Immune Correlates of Long-term Survival after Delta-24-RGD Based on the Therapeutic Adenovirus for Recurrent Glioblastoma Effect Trial (TARGET).

Chibawanye I Ene, Sanjay Singh, Thiagarajan Venkataraman

|Nov 14, 2025
Microbial signals in primary and metastatic brain tumors.

Golnaz Morad, Ashish V Damania, Brenda Melendez

|Jul 21, 2025
Author Correction: Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial.

Farshad Nassiri, Vikas Patil, Leeor S Yefet

|Nov 27, 2024
Oncolytic Virotherapies and Adjuvant Gut Microbiome Therapeutics to Enhance Efficacy Against Malignant Gliomas.

Natalie M Meléndez-Vázquez, Candelaria Gomez-Manzano, Filipa Godoy-Vitorino

|Nov 13, 2024
Immunotherapy-related neurotoxicity in the central nervous system of children with cancer.

Jiasen He, Jeremy Connors, Andrew Meador

Pageof 3

Frequent Collaborators

8 joint publications

Juan Fueyo

7 joint publications

Marta Zalacain

5 joint publications

Frederick F Lang

3 joint publications

Dong Ho Shin